4//SEC Filing
Johnson Kevin C 4
Accession 0001077183-21-000160
CIK 0001077183other
Filed
Jun 3, 8:00 PM ET
Accepted
Jun 4, 7:58 PM ET
Size
10.3 KB
Accession
0001077183-21-000160
Insider Transaction Report
Form 4
Johnson Kevin C
Director
Transactions
- Award
Stock Options (Right to Buy)
2021-06-02+3,714→ 3,714 totalExercise: $40.90From: 2022-06-02Exp: 2028-06-02→ Common Stock (3,714 underlying) - Award
Common Stock
2021-06-02+3,081→ 34,064 total
Holdings
- 4,269
Stock Options (Right to Buy)
Exercise: $22.52From: 2020-06-06Exp: 2026-06-06→ Common Stock (4,269 underlying) - 3,334
Stock Options (Right to Buy)
Exercise: $7.27Exp: 2022-05-25→ Common Stock (3,334 underlying) - 3,448
Stock Options (Right to Buy)
Exercise: $28.54From: 2021-05-28Exp: 2027-05-28→ Common Stock (3,448 underlying)
Footnotes (1)
- [F1]On May 25, 2017, Mr. Johnson was granted 10,000 stock options. The options vested ratably over the first three anniversary dates of the grant date.
Documents
Issuer
NEOGENOMICS INC
CIK 0001077183
Entity typeother
Related Parties
1- filerCIK 0001353436
Filing Metadata
- Form type
- 4
- Filed
- Jun 3, 8:00 PM ET
- Accepted
- Jun 4, 7:58 PM ET
- Size
- 10.3 KB